CLINICAL_TRIALS
trial_result
· 2016-01-20
Clinical Trial Update: LAL-BR/2001: Study Treatment to Low Risk ALL [Phase 4]
Summary
Phase 4 trial LAL-BR/2001 assessing treatment for low-risk acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: COMPLETED